Clinical Trials Browser

Phase 2 × Teniposide × 90 days × Clear all

NCT07583511 2026-05-13

Teniposide, Cisplatin and Serplulimab for Treatment of ES-SCLC, a Randomized Controlled Study

Phase 2 Recruiting

Small Cell Lung Carcinoma